{
  "ticker": "ALA",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02960867",
  "id": "02960867",
  "pages": 6,
  "price_sensitive": false,
  "date": "20250623",
  "time": "0934",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250623/pdf/06l02lpp47k92l.pdf",
  "summary": "### **Summary of ASX Announcement \u2013 AROVELLA THERAPEUTICS LIMITED**  \n**Announcement Type:** *Appendix 2A \u2013 Securities Quotation Application*  \n\n- **New Securities Issued:** **750,000 ordinary shares (ALA)** from conversion of options (ALAAA).  \n- **Issue Date:** **24 June 2025**.  \n- **Exercise Price:** **AUD $0.0675 per share**.  \n- **Post-Issue Capital Structure:**  \n  - Ordinary shares (ALA): **1,185,338,109**  \n  - Quoted options (ALAO): **155,803,175** (expiring 24-May-2027)  \n  - Unquoted options: **75,881,317** (ALAAE + ALAAA).  \n- **Ranking:** New shares rank equally with existing ordinary shares.  \n\n**Material Impact:** Minor dilution (~0.06% increase in ordinary shares) from low-value option conversion. No cash raised.",
  "usage": {
    "prompt_tokens": 1463,
    "completion_tokens": 212,
    "total_tokens": 1675,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-06-22T23:41:51.366120"
}